MS Morgan Stanley

$MS $GS After the recent stumbling in the ipo calendar thanks to Anthropic and OpenAi twirling, last week’s bond mkt follies and more endless Trump drivel on Iran crap, I came to the view that the financials are bottoming on bs… When the turnaround becomes apparent, the pile in will begin and likely be violent to the upside. I reloaded both names Friday. LONG 25K of MS AND 3k of GS. F the big banks and their massively underwater bond portfolios going back to Covid nonsense days and super low zero bond rates… they are hosed for years on those butch allocations. Imo, you just own the two best names, MS GS. The financials are trading at record lows….TIME TO WADE IN ON A BG SWING TRADE.

Kalshi has raised $1B in a Series G funding round, valuing the company at $40B - About 5 months ago, Kalshi raised $1B in a previous round, which valued the company at $22B The funding round was co-led by Wellington and Sequoia, with Andreessen Horowitz, Coatue, Baillie Gifford, $MS Investment Management, CapitalG, & other investors also participating. Kalshi reported that its annualized trading volume now tops $1T, while annualized non-sports revs has surpassed $1B. Over 30M accounts have been opened on the platform, where over 75% of prediction market trading volume is happening. Perpetual futures business generated $83B in trading volume since launch several months ago. International retail business: approaching $100M in annualized trading fees, one year after expanding into 140+ countries. Institutional participation: rising; approx. 500 entities traded on the platform in Sept. Kalshi plans to direct the new investment toward new trading products, greater institutional participation, and expansion into international markets. The company also recently announced plans to develop prediction market indices w/ $SPGI ​$FLUT $DKNG $HOOD

$MS : “Of all the concerns, we think liquidity presents the biggest risk and catalyst for a final low,” the strategist said. But didn’t $SPCX just do 40B and $AVGO another 63B and $META 95B secondary and OpenAI about to do 30b and $ANT.X another 100B!? ….

Sentiment track for companies reporting tomorrow morning. $MS occupies the Extremely Bullish zone alone. $ASML is exhibiting the steepest ascent moving from the Bearish zone to the top edge of the Bullish zone. $SOTK is the only name to have been in the Extremely Bullish zone yet had fallen hard into the Bearish zone. Other large financials $BLK and $BAC in the Bullish zone.

$MS $GS Have flip traded 7k (3 trades) of gs this week for just under $26K. Added 8k to the 25k ms swing rebought this week. Both report next week. Will reload 5k gs Monday if no nukes fired on Iran. Rip Rip!

$MS looks as if price digested ER at the end of a regular abc-correction. means it's ready for a fresh run, 25% below ATH

$MS This should be in $200 s today. No reason for it to go down on an earnings beat with other loser banks.

$MS Key Metrics vs. Consensus: • EPS: $3.03 (vs. $2.91 expected) 🚀 • Revenue: $20.34B (vs. $19.95B expected) 📈 (+12% YoY) • Net Income: $4.91B | ROTCE: 22.6% Segment Highlights: • Institutional Securities: $10.03B (vs. $9.21B exp) • Equities: $5.80B (Smashed $4.90B exp by ~$1B!) 🤯 • IB Revenue: $2.16B (In line with estimates) • Wealth Management: $9.1B revenue (30.4% margin). Added $232B net new assets. • Investment Management: $1.46B revenue ($2.05T total AUM). Capital Returns: $1.5B in stock buybacks; $1.15/share dividend. Takeaway: Blowout quarter driven by a massive $1B beat in equities trading and relentless wealth inflows.

$MS bought some more on the pullback. If earnings are good and we climb tomorrow then I’ll have made a good choice. If it tanks I will double my position as I have money coming soon

$MS With all the ai financing happening, next week will be the bullish of the year. 80 billion loan for Amazon ai.

$MS OptionsFLO flow and daily chart read. The alert snapshot shows $1.3M in the Oct 30 $180 calls. Volume was 2.2x standing open interest at capture. Daily chart through Oct 29: last close $190.00, above its 20 day average and below its 50 day average, with RSI at 51. The 3 month range is $176.44 to $222.00. Intraday volume does not establish whether a position was opened or held; the next settled open interest is the check.

$MS 10T assets under management. Average 12-Month Price Target: ~$214 to $218 (representing a ~14%–18% potential upside from current trading levels near $190.

https://www.cnbc.com/investingclub/2026/10/26/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension $MS $GS Anthropic drops its long-awaited IPO prospectus. The frontier AI lab plans to list on the Nasdaq under ticker symbol ANT. No terms; that will come later, after the roadshow. Morgan Stanley and Club name Goldman Sachs are named as top underwriters. Before the filing, speculation put the valuation of the company behind Claude at as much as $2 trillion.

$MS (Morgan Stanley, the investment bank and wealth manager) earned $3.03 a diluted share in Q3 2026, down 12% from Q2's $3.46, as net revenues fell 5% to $20.3B and trading revenue dropped 17% from Q2. That is $4.9B of quarterly profit for a firm valued near $298B at the Oct 12 close of $190.02. Other side: vs Q3 2025, revenue rose 12% and EPS rose from $2.80; Wealth Management posted record revenue of $9.1B and $232B of net new assets, just over half tied to IPOs. Next: $1.15 quarterly dividend, record Oct 30, paid Nov 13.

$MS | Q3 2026 Post-Earnings Research Update Rating: BUY 12-Month Price Target: $219.00 (+17.7% upside vs. $186.00) Horizon: 12 Months Core Thesis: Morgan Stanley's Q3 results validate its hybrid compounder model, as record Wealth Management revenue ($9.1B at a 30.4% pre-tax margin) and $10.5T in total client assets anchor valuation while M&A advisory (+30% YoY) and Equities trading (+41% YoY) drive upside. Q3 Key Takeaways & Valuation: - Revenue: $20.34B (+11.6% YoY) | GAAP EPS: $3.03 (+8.2% YoY) | ROTCE: 22.6% - Wealth Management NNA hit $232B ($80B fee-based flows) with rising NII, refuting sweep-account margin compression fears. - Weighted Fair Value: $219.00 (50% SOTP: $224.50, 35% RIM: $218.25, 15% DDM: $203.80). Key Risk & Catalyst: Soft Investment Management (-12% YoY) and equity underwriting (-19.5% YoY) caused a minor pullback, offering an entry backed by a 14.9% CET1 ratio and $1.5B Q3 buybacks. Not investment advice.

$MS Morgan Stanley reported an 11.6% year-over-year increase in Q3 revenue to $20.338 billion, beating Fiscal AI’s estimate of $20.1096 billion.

$MS Morgan Stanley printed 3.03 dollars in Q3, ahead of the 2.93 dollars FactSet had, on 20.34 billion dollars of revenue, up about 12 percent from a year ago. Equities did the heavy lifting again, 5.79 billion dollars, up 41 percent, while fixed income fell 7 percent to 2.01 billion dollars. Wealth came in at 9.07 billion dollars, up 10 percent, and investment banking added 2.16 billion dollars, up just 2 percent. Net income was 4.97 billion dollars.

$MS | MORGAN STANLEY Q3 2026 EARNINGS HIGHLIGHTS ◆ EPS: $3.03 vs. $2.93 est. ✅ ◆ Revenue: $20.34B vs. $19.93B est. ✅ ◆ Net Interest Income: $3.25B (+30.5% YoY) ◆ Net Income: $4.91B (+6.5% YoY) ◆ Provision for Credit Losses: $148M ◆ Non-Interest Expense: $13.71B (+12.4% YoY) Segment Performance: ◆ Institutional Securities: $10.03B (+17.7% YoY) ◆ Wealth Management: $9.07B (+10.1% YoY) ◆ Investment Management: $1.46B (-11.6% YoY) Key Metrics: ◆ Equity net revenues rose 41% YoY to $5.80B, driven by client engagement and strength in Asia. ◆ Share repurchases totaled $1.54B in Q3 2026 at an average price of $212.74; board declared $1.15 quarterly dividend per share. ◆ Standardized CET1 capital ratio was 14.9% at quarter-end, down from 15.1% a year ago. Forward Guidance: ◆ No guidance provided

$MS easy dip to buy. Nothing bad here. NNA growth and client asset growth QoQ even strong.

$MS | Equity Research Update Rating: BUY 12-Month Price Target: $219.00 (+15.3% upside vs. $190.02) Horizon: 12 Months Core Thesis: Morgan Stanley’s premier Wealth Management franchise (>53% fee-based revenue) dampens trading volatility while providing operating leverage into an accelerating global M&A and IPO underwriting recovery. Valuation Framework: • SOTP Model: $224.50 (18.5x WM / 13.5x IS P/E) • Residual Income Model: $218.25 (19.0% ROTCE vs. 9.85% Ke) • Capital Return DDM Floor: $203.80 Weighted Fair Value: $219.00 (3.7x forward P/TBV) Catalysts & Balance Sheet: • Q3 2026 earnings tomorrow pre-market (Consensus: $2.94 EPS / $20.19B revenue). • Capital return underpinned by 15.2% CET1 ratio, $4.60/yr dividend, and $20B buyback authorization. Primary Risk (Pre-Mortem Stress Test): Deposit beta headwinds and sweep-account yield adjustments pressuring Wealth Management net interest income. Not investment advice.